- ►diabetesjournals.org MJ Brown, SJ Bird, S Watling, H Kaleta, L … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Patients from a multicentered trial of zenarestat,
an aldose reductase inhibitor, had serial measures of neurologic function,
including nerve conduction studies (NCSs), quantitative sensory testing ... Cited by 18 - Related articles - BL Direct - All 5 versions
SJ Bird, MJ Brown, C Spino, S Watling, HL … - Muscle and Nerve, 2006 - wrmed.com Table 4. Effect of increasing the number of replicates on sample size per
treatment arm, based on baseline variance.* Sample size* Quantitative sensory
Nerve conduction velocity Amplitude F-wave latency testing Median Number of ... Cited by 15 - Related articles - BL Direct - All 4 versions
[CITATION] A simple diabetes neuropathy screening scale can predict measurable sural sensory …
F Kinekawa, F KUBO, K MATSUDA, Y FUJITA … - Hepato-gastroenterology, 2005 - cat.inist.fr Background/Aims: Disorders of the digestive tract in diabetic patients are
mainly ascribed to disorders of the vagus nerve. Although aldose reductase
inhibitors(ARIs) have been shown to be effective against diabetic ... Cited by 6 - Related articles - All 3 versions
- Free from Publisher V Bril, Y Ono, RA Buchanan - Diabetes care, 2004 - Am Diabetes Assoc OBJECTIVE—Nerve sorbitol levels have been measured in sural nerve biopsy
samples from patients with diabetic sensorimotor polyneuropathy in several
studies using different methods and measurement units. In this study, we ... Cited by 7 - Related articles - BL Direct - All 6 versions
- Free from Publisher V Bril, RA Buchanan - Diabetes Care, 2004 - Am Diabetes Assoc OBJECTIVE—The primary purpose of this investigation was to determine whether
AS-3201, a new aldose reductase inhibitor, penetrates the sural nerve and
inhibits sorbitol and fructose accumulation in patients with diabetic ... Cited by 48 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org S Tesfaye, R Tandan, EJ Bastyr, KA Kles, V … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—After 1 year, change in the neuropathy impairment score of lower limbs
[NIS(LL)] (−0.63 points; P = 0.005), vibration detection threshold (VDT)
(−0.42 just noticeable difference units; P = 0.003), and Neuropathy Total ... Cited by 9 - Related articles - BL Direct - All 4 versions
- Free from Publisher V Bril, RA Buchanan - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Patients with mild to moderate DSP, as determined
by the presence of sural nerve responses, were enrolled in a double-blind,
placebo-controlled biopsy trial and randomized to placebo or 5 or 20 mg/day ... Cited by 44 - Related articles - BL Direct - All 6 versions
N Nakamura, K Yamazaki, A Satoh, M … - In vivo (Athens, Greece) - ncbi.nlm.nih.gov Advanced glycation end products (AGE) are produced by a nonenzymatic reaction
between glucose and proteins in the plasma of diabetic patients. Recently, AGE
have been reported to promote and accelerate diabetic complications and ... Cited by 13 - Related articles - BL Direct
